Bluejay Diagnostics, Inc.

BJDX ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2022
Revenue $249.0K
Cost of Revenue $200.1K
Gross Profit $48.9K
Gross Margin 19.6%
Operating Expenses
Research & Development $756.3K
SG&A Expense $1.2M
Operating Income $-2.0M
Operating Margin -797.4%
Interest Expense —
Pretax Income —
Income Tax Expense —
Net Income $-1.9M
Net Margin -777.9%
EPS (Basic) $-0.20
EPS (Diluted) $-0.20
Shares Outstanding (Basic) 10.1M
Shares Outstanding (Diluted) 10.1M
Dividends Per Share —